INTECH Investment Management’s MaxCyte MXCT Stock Holding History
Bought
Maintained
Sold
Other funds holding MXCT
CFM
VP
MA
BFM
CCM
PLC
INTECH Investment Management's MXCT Position: Q2 2026 in Review
INTECH Investment Management sold out of MaxCyte (MXCT) in Q2 2026, closing a stake of 27,027 shares — an estimated $19K sold.
INTECH Investment Management first reported a position in MXCT in Q3 2024 and held it in 7 quarters. The position peaked at $165K in Q1 2025. 122 funds tracked by Wall St. Rank hold MXCT as of Q2 2026.
- INTECH Investment Management reported no remaining MaxCyte position as of Q2 2026 after selling out during the quarter.
- INTECH Investment Management sold 27,027 MaxCyte shares in Q2 2026, an estimated $19K.
- INTECH Investment Management first reported a position in MaxCyte in Q3 2024 and held it in 7 quarters.
- INTECH Investment Management's MaxCyte position peaked at $165K in Q1 2025.
- 122 funds tracked by Wall St. Rank held MaxCyte as of Q2 2026.
Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.